| Product Name | MF | CAS | Details |
|---|
| BLU2864 | C24H19F3N4O2 | 2810747-89-6 | Details |
| Chlorantraniliprole | C18H14BrCl2N5O2 | 500008-45-7 | Details |
| Cis-22a | C24H30F3N3O2 | 1819366-84-1 | Details |
| TUG-499 | C16H11Cl2NO2 | 1206629-08-4 | Details |
| 1H-Pyrrolo[2,1-c][1,2,4]benzothiadiazine, 2,3,3a,4-tetrahydro-, 5,5-dioxide, (3aR)- | C10H12N2O2S | 175340-21-3 | Details |
| Perilipin-1/5 Inhibitor 1 | C23H24N2O6S | 847939-23-5 | Details |
| Chromium(III) acetate | C2H4CrO2 | 1066-30-4 | Details |
| Vocacapsaicin hydrochloride | C26H42ClN3O4 | 1931116-92-5 | Details |
| Anti-inflammatory agent 36 | C25H27NO7 | 2293951-01-4 | Details |
| (2S,5S)-3,6-Dioxo-2,5-piperazinediacetamide | C8H12N4O4 | 88206-98-8 | Details |
| PFM39 | C10H9N3OS | 1310744-67-2 | Details |
| G6Pase catalytic subunit 1 inhibitor 1 | C20H19N3 | 237402-29-8 | Details |
| SH-42 | C25H38O4 | 2143952-36-5 | Details |
| 5-A-RU-PABC-Val-Cit-Fmoc | C43H53N9O13 | 2677841-58-4 | Details |
| Amthamine 2HCl | C6H12ClN3S | 136604-58-5 | Details |
| FPI-1523 sodium | C9H15N4NaO7S | 1452459-52-7 | Details |
| (Hyp3)-Bradykinin acetate | Details |
| YM 534 | C24H36N2O4 | 95923-66-3 | Details |
| 1-(3,4-Dihydroxyphenyl)-2-(dimethylamino)ethanone HCl | C10H14ClNO3 | 16899-83-5 | Details |
| Simpinicline | C10H13N3 | 753015-44-0 | Details |
| Isonicotinaldehyde 2-pyridinylhydrazone | C11H10N4 | 2241017-37-6 | Details |
| Hu7691 free base | C22H21F3N4O | 2241232-43-7 | Details |
| CG 428 | C43H43FN10O6 | 2412055-93-5 | Details |
| SPEN-IN-1 | C27H20N4O | 2863686-82-0 | Details |
| mTOR inhibitor 9f | C25H23N5O2S | 1144075-42-2 | Details |
| L-Valyl-L-phenylalanine HCl | C14H21ClN2O3 | 128090-87-9 | Details |
| KER047 | C26H30FN7O | 2248154-85-8 | Details |
| IMP-1710 | C23H19N5O | 2383117-96-0 | Details |
| Xemilofiban | C18H22N4O4 | 149820-74-6 | Details |
| YM 16638 | C18H22N2O5S3 | 104073-72-5 | Details |
| mTOR inhibitor 9b | C21H23N5O2S | 1144075-34-2 | Details |
| 1-(1-phenyltetrazol-5-yl)piperazine HCl | C11H15ClN6 | 1171471-37-6 | Details |
| 3,4,5-Trihydroxycinnamic acid decyl ester | C19H28O5 | 1770778-45-4 | Details |
| 1-(7-carbamimidamidoheptyl)guanidine 2HCl | 2193061-39-9 | Details |
| 6'-GNTI dihydrochloride | C27H30ClN5O3 | 2410327-94-3 | Details |
| Nrf2 activator-1 | C30H34N4O6S | 2230697-41-1 | Details |
| Dynamin IN-2 | C22H21ClN2O | 1345853-49-7 | Details |
| YT 146 | 90596-75-1 | Details |
| BLU0588 | C26H25N5O | 2810747-78-3 | Details |
| Y13g dihydrochloride | Details |
| 3-(2,6-dichlorobenzyl)-1-hexadecyl-2-methyl-1H-imidazol-3-ium iodide | Details |
| 1-{1H-pyrrolo[2,3-d]pyrimidin-4-yl}piperazine 2HCl | C10H14ClN5 | 853680-06-5 | Details |
| 3-Ethyl-1-methyl-2-thioxoimidazolidin-4-one | C6H10N2OS | 64895-98-3 | Details |
| BTT-266 | C34H28N4O4 | 2413939-89-4 | Details |
| (Iso)-RJW100 | C28H34O | 1276664-61-9 | Details |
| (S, R)-LSN 3318839 | C26H23Cl2N3O2 | 2765539-92-0 | Details |
| ALK/ROS1 inhibitor 2e HCL | Details |
| CYP2A6-IN-1 | C12H16F3N | 912291-11-3 | Details |
| (Sar1)-Angiotensin II acetate | C51H75N13O12 | 102029-89-0 | Details |
| ABI-1968 | C35H58N5O6P | 1626364-18-8 | Details |
| 3-phenoxy-8-azabicyclo[3.2.1]octane HCl | C13H18ClNO | 1955540-15-4 | Details |
| CAY10703 HCl | 2193060-78-3 | Details |
| Benzo[b]thiophene-7-propanoic acid, α-methoxy-4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]-, (αR)- | C24H23NO5S | 849150-59-0 | Details |
| mTOR inhibitor 9c | C21H22FN5O2S | 1144075-36-4 | Details |
| Aβ-IN-1 TFA | Details |
| Lifitegrast | C29H24Cl2N2O7S | 1025967-78-5 | Details |
| 1-[(5-Chloro-2-thienyl)sulfonyl]proline | C9H10ClNO4S2 | 1007999-30-5 | Details |
| PDD00017272 | C23H25N5O4S3 | 1945950-20-8 | Details |
| JAK3-IN-14 | C18H13N3O | 454234-24-3 | Details |
| 1-(2-fluorophenyl)-3-[5-(2-methoxyphenyl) | C16H13FN4O2S | 426242-86-6 | Details |
| 1H-Pyrazole-5-carboxamide, 4-(5-chloro-2-furanyl)-1,3-bis(2,4-difluorophenyl)-4,5-dihydro-5-methyl-N-[(4-methyl-2-morpholinyl)methyl] | C27H25ClF4N4O3 | 2171015-78-2 | Details |
| ERα degrader-2 | C29H27F3N2O2 | 2235396-63-9 | Details |
| Cell-cell interaction 1 | C22H30N4O2 | 918328-92-4 | Details |
| BRD4 Inhibitor 31 | C11H14N2O | 56369-21-2 | Details |
| AM-8123 | C27H33N7O5S | 2049973-02-4 | Details |
| Thalidomide-NH-CH2-COOH TFA | 2377032-39-6 | Details |
| DP-1 hydrochloride | C26H32ClN5O3 | 1472616-35-5 | Details |
| mTOR inhibitor-8 | C24H19ClN4OS | 2489196-70-3 | Details |
| 2-Oxo-6-phenyl-1,2,3,6-tetrahydro-pyrimidine-4-carboxylic acid | C11H10N2O3 | 304443-33-2 | Details |
| Neuroprotective agent 1 | C14H10F6N2O3 | 1878204-21-7 | Details |
| Neramexane HCl | C11H24ClN | 209185-99-9 | Details |
| Antiviral agent 38 | C23H27N3O5 | 2247932-38-1 | Details |
| AChE-IN-3 | C25H21N3O4 | 2713548-95-7 | Details |
| mTOR inhibitor 9a | C20H21N5O2S | 1144075-32-0 | Details |
| WDR5-47 | C19H20ClFN4O3 | 1422389-91-0 | Details |
| Tyrphostin AG 538 | C16H11NO5 | 133550-18-2 | Details |
| 1H-Indole-3-carboxylic acid, 5-[2-hydroxy-3-[[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino]propoxy]-2-methyl-1-(4-methylphenyl)-, ethyl ester | C26H34N2O7 | 539807-13-1 | Details |
| FLT3 kinase inhibitor 2HCl | C25H28ClN7O2 | 2411178-94-2 | Details |
| HDAC1/5-IN-1 | C26H23N3O2 | 380463-49-0 | Details |
| Antibacterial agent 170 | C10H7Br2N3O3S | 2163817-03-4 | Details |
| 1-(3-chloropyridin-2-yl)piperazine 2HCl | C9H13Cl2N3 | 1193389-39-7 | Details |
| PF-07038124 HCl | C18H22BNO4.ClH | 2415317-57-4 | Details |
| Geranylgeranyl pyrophosphate, t-BA (1:1.5) | Details |
| (S)-Vamicamide | C18H23N3O | 151851-72-8 | Details |
| Anticonvulsant agent 10 HCl | 1818253-48-3 | Details |
| (S)-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-2-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-7-carboxamide | C26H23F3N6O | 1934246-20-4 | Details |
| 1-(8-carbamimidamidooctyl)guanidine 2HCl | C10H26Cl2N6 | 25303-05-3 | Details |
| 4-Methylhistamine hydrochloride | C6H12ClN3 | 84103-51-5 | Details |
| GLP-1R modulator C16 | C21H26ClFN2O3 | 875005-43-9 | Details |
| mTOR inhibitor 9e | C22H23N5O2S | 1144075-40-0 | Details |
| mTOR inhibitor 9d | C21H23N5O3S | 1144075-38-6 | Details |
| Antitumor agent-152 | C17H19N5O2S2 | 1209784-87-1 | Details |
| Compound STK672155 | C27H21ClN2O7S | 339284-01-4 | Details |
| Compound V007-6018 | C30H24F6N4O2S | 859093-06-4 | Details |
| Antibacterial agent 171 | C18H21NO4S | 1354546-42-1 | Details |
| SW2_110A | C42H60N6O7 | 2579696-95-8 | Details |
| EM-651 | C29 H31 N O4 | 182167-58-4 | Details |
| 4-(3-Chlorophenyl)-2(3H)-thiazolone | C9H6ClNOS | 1095051-68-5 | Details |
| Product Total： Product Page： | ||||
| 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 | ||||